IFN-gamma production from liver mononuclear cells of mice in burn injury as well as in postburn bacterial infection models and the therapeutic effect of IL-18

J Immunol. 2002 Oct 15;169(8):4437-42. doi: 10.4049/jimmunol.169.8.4437.

Abstract

Hosts after severe burn injury are known to have a defect in the Th1 immune response and are susceptible to bacterial infections. We herein show that liver NK cells are potent IFN-gamma producers early after burn injury. However, when mice were injected with LPS 24 h after burn injury, IFN-gamma production from liver mononuclear cells (MNC; which we previously showed to be NK cells) was suppressed, and the serum IFN-gamma concentration did not increase, while serum IL-10 conversely increased compared with control mice. Interestingly, a single injection of IL-18 simultaneously with LPS greatly restored the serum IFN-gamma concentration in mice with burn injury and also increased IFN-gamma production from liver MNC. Nevertheless, a single IL-18 injection into mice simultaneously with LPS was no longer effective in the restoration of serum IFN-gamma and IFN-gamma production from the liver MNC at 7 days after burn injury, when mice were considered to be the most immunocompromised. However, IL-18 injections into mice on alternate days beginning 1 day after burn injury strongly up-regulated LPS-induced serum IFN-gamma levels and IFN-gamma production from liver and spleen MNC of mice 7 days after burn injury and down-regulated serum IL-10. Furthermore, similar IL-18 therapy up-regulated serum IFN-gamma levels in mice with experimental bacterial peritonitis 7 days after burn injury and greatly decreased mouse mortality. Thus, IL-18 therapy restores the Th1 response and may decrease the susceptibility to bacterial infection in mice with burn injury.

MeSH terms

  • Animals
  • Bacterial Infections / etiology
  • Bacterial Infections / immunology*
  • Bacterial Infections / mortality
  • Bacterial Infections / therapy
  • Burns / complications
  • Burns / immunology*
  • Burns / therapy
  • Cells, Cultured
  • Down-Regulation / immunology
  • Drug Administration Schedule
  • Injections, Intraperitoneal
  • Injections, Intravenous
  • Interferon-gamma / biosynthesis*
  • Interferon-gamma / blood
  • Interleukin-10 / antagonists & inhibitors
  • Interleukin-10 / biosynthesis
  • Interleukin-18 / administration & dosage
  • Interleukin-18 / therapeutic use*
  • Killer Cells, Natural / immunology*
  • Killer Cells, Natural / metabolism*
  • Lipopolysaccharides / administration & dosage
  • Lipopolysaccharides / antagonists & inhibitors
  • Liver / cytology
  • Liver / immunology*
  • Liver / metabolism*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Peritonitis / etiology
  • Peritonitis / immunology
  • Peritonitis / mortality
  • Peritonitis / therapy
  • Spleen / cytology
  • Spleen / immunology
  • Spleen / metabolism
  • Treatment Failure
  • Up-Regulation / immunology

Substances

  • Interleukin-18
  • Lipopolysaccharides
  • Interleukin-10
  • Interferon-gamma